Drug Search Results
More Filters [+]

Trypan blue

Alternative Names: trypan blue, membraneblue, visionblue
Latest Update: 2022-08-15
Latest Update Note: Clinical Trial Update

Product Description

The protocol described in this appendix allows for light microscopic quantitation of cell viability. Cells are suspended in PBS containing trypan blue and then examined to determine the percentage of cells that have clear cytoplasm (viable cells) versus cells that have blue cytoplasm (nonviable cells). (Sourced from: https://pubmed.ncbi.nlm.nih.gov/26529666/)

Mechanisms of Action: Contrast Agent

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Injection

FDA Designation: None *

Approval Status: Approved

Approved Countries: Bangladesh | Colombia | Dominican Republic | India | Philippines | Thailand | United Kingdom | United States

Approved Indications: None

Known Adverse Events: None

Company: Monash Health
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Trypan blue

Countries in Clinic: Australia

Active Clinical Trial Count: 1

Highest Development Phases

Phase 1: Cerebral Palsy|Obstetric Labor, Premature

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CORD-SAFE study

P1

Recruiting

Cerebral Palsy|Obstetric Labor, Premature

None

Recent News Events

Date

Type

Title